发明名称 |
THERAPEUTIC HUMANISED ANTIBODIES AGAINST CD45 ISOFORMS |
摘要 |
<p>A molecule comprising at least one antigen binding site, comprising in sequence the hypervariable regions CDR1, CDR2 and CDR3, said CDR1 having the amino acid sequence Asn-Tyr-Ile-IIe-His (NYIIH), said CDR2 having the amino acid sequence Tyr-Phe-Asn-ProTyr-Asn-His-Gly-Thr-Lys-Tyr-Asn-Glu-Lys-Phe -Lys-Gly (YFNPYNHGTKYNEKFKG) and said CDR3 having the amino acid sequence Ser-Gly-Pro-Tyr-Ala-Trp-Phe-Asp-Thr (SGPYAWFDT); e.g. further comprising in sequence the hypervariable regions CDR1', CDR2' and CDR3', CDR1' having the amino acid sequence Arg-Ala-Ser-Gln-Asn-Ile-GIy-ThrSer-IIe-Gln (RASQNIGTSIQ), CDR2' having the amino acid sequence Ser-Ser-Ser-Glu-SerIle-Ser (SSSESIS) and CDR3' having the amino acid sequence Gln-GIn-Ser-Asn-Thr-Trp Pro-Phe-Thr (QQSNTWPFT), e.g. a chimeric or humanised antibody, useful as a pharmaceutical.</p> |
申请公布号 |
EP1664122(B1) |
申请公布日期 |
2010.03.17 |
申请号 |
EP20040765363 |
申请日期 |
2004.09.17 |
申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH |
发明人 |
KOLBINGER, FRANK;CARBALLIDO HERRERA, JOSE, M.;ASZODI, ANDRAS;SALDANHA, JOSE W.;HALL, BRUCE, M.;GREGORI, SILVIA;RONCAROLO, MARIA GRAZIA;LOUX, VERONIQUE;AVERSA, GREGORIO;JESCHKE, MARGIT |
分类号 |
C07K16/28;A61K39/395;A61P37/00;C12N5/10;C12N15/13;C12N15/62;C12N15/79 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|